Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion type Assertion NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_head.
- NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion description "[NRP2 is a robust biomarker for predicting response to IGF-IR therapy because prostate carcinomas that express NRP2 exhibit low levels of IGF-IR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_provenance.
- NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion evidence source_evidence_literature NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_provenance.
- NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion SIO_000772 22777769 NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_provenance.
- NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion wasDerivedFrom befree-20140225 NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_provenance.
- NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_assertion wasGeneratedBy ECO_0000203 NP661009.RArPMr4Ae_K1_tTyj5OBRCKVndvWnYKzUMh2ekSB2XxiI130_provenance.